Therapeutics Acquisition Corp. (TXAC) Prices Upsized $118M IPO
Therapeutics Acquisition Corp. (TXAC), announced the pricing of their upsized $118 million SPAC IPO this afternoon and the shares are currently trading under the symbol Nasdaq: TXAC.
Therapeutics Acquisition Corp. is being sponsored by RA Capital Management, L.P., ...READ MORE
